Elevance Health Raises 2026 Earnings Outlook Following Strong Q2 Performance
Elevance Health (NYSE:ELV) raised its full-year adjusted EPS outlook to at least $27 per share after reporting better-than-expected second-quarter results. The company cited strong performance in Medicare Advantage and ACA, along with disciplined cost management.
Tickers: $ELV
Topics: financial guidance healthcare insurance